Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Astaxanthin and Reduced Uric Acid Levels

Doses used in studies

mg/day: 20 (median 20, IQR 20–20) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
The abstract does not mention any adverse events or side effects related to astaxanthin supplementation.
from: Impact of astaxanthin on oxidative markers, uric acid, and clinical symptoms in heart fail

1 of 1 paper

Impact of astaxanthin on oxidative markers, uric acid, and clinical symptoms in heart failure: a randomized clinical trial.
- 2025-10-29
- RCT · n = 80
- BMC cardiovascular disorders 25(1)
- - Shirin Ghotboddin Mohammadi
  - Davood Shafie
  - Awat Feizi
  - Mohammad Bagherniya
  - Ali-Reza Ahmadi
  - Marzieh Kafeshani
- PubMed: 41162864
- DOI: 10.1186/s12872-025-05260-z
7 Insights on
- Reduced Uric Acid Levels
- High evidence
- Clinical
the ASX group demonstrated significantly greater reductions in ... serum UA levels (-1.82 vs. -0.63 mg/dl, P = 0.003)
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
20 mg/day